title: Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.
abstract: Human papillomavirus (HPV) E6/E7 mRNA has been proposed as a more specific marker for cervical dysplasia and cancer than HPV DNA. This study evaluated the RNA specificity of nucleic acid sequence-based amplification (NASBA)-based HPV detection using HPV DNA plasmids (HPV type 16 [HPV16], HPV18, HPV31, HPV33, and HPV45) and nucleic acid extracts of several cell lines, which were systematically subjected to enzymatic treatments with DNase and RNase. HPV plasmid dilutions (10(6) to 10(0) copies/microl) and nucleic acid extracts (total DNA, RNA-free DNA, total RNA, and DNA-free RNA) of unfixed and fixed (PreServCyt and SurePath) HaCaT, HeLa, and CaSki cells were tested with the NucliSENS EasyQ HPV test. The RNA-free DNA extracts of HeLa and CaSki cells could be amplified by HPV18 and -16 NASBA, respectively. Fixation of the cells did not influence NASBA. All HPV plasmids could be detected with NASBA. Based on the plasmid dilution series, a lower detection limit of 5 x 10(3) HPV DNA copies could be determined. Our study identified viral double-stranded DNA as a possible target for NASBA-based HPV detection. The differences in diagnostic accuracy between the NASBA-based tests and conventional HPV DNA detection assays seem to be attributable not to the more specific amplification of viral mRNA but to the limited type range and the lower analytical sensitivity for HPV DNA.
authors.affiliation: University of Antwerp, Laboratory for Cell Biology and Histology, Antwerp, Belgium. gaelle.boulet@ua.ac.be
authors.forename: Gaëlle A V
authors.initials: GA
authors.lastname: Boulet
authors.forename: Isabel M
authors.initials: IM
authors.lastname: Micalessi
authors.forename: Caroline A J
authors.initials: CA
authors.lastname: Horvath
authors.forename: Ina H
authors.initials: IH
authors.lastname: Benoy
authors.forename: Christophe E
authors.initials: CE
authors.lastname: Depuydt
authors.forename: Johannes J
authors.initials: JJ
authors.lastname: Bogers
mesh_terms: D052685:Alphapapillomavirus / Q000145:classification / Q000235:genetics; D045744:Cell Line, Tumor; D004279:DNA, Viral / Q000032:analysis / Q000302:isolation & purification; D006367:HeLa Cells; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D030361:Papillomavirus Infections / Q000821:virology; D010957:Plasmids / Q000235:genetics; D012367:RNA, Viral / Q000032:analysis / Q000302:isolation & purification*; D015203:Reproducibility of Results; D014773:Virology / Q000379:methods*
chemical_list: D004279:DNA, Viral; D012367:RNA, Viral
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/26-34
references.pmid: 16950015
references.citation: J Mol Diagn. 2006 Feb;8(1):113-8
references.pmid: 16436642
references.citation: J Clin Microbiol. 2009 Dec;47(12):3895-901
references.pmid: 19828739
references.citation: Vaccine. 2008 Aug 19;26 Suppl 10:K42-52
references.pmid: 18847556
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3033-42
references.pmid: 18957520
references.citation: J Clin Pathol. 2008 Jan;61(1):132-7
references.pmid: 17468293
references.citation: J Clin Microbiol. 2009 Aug;47(8):2458-64
references.pmid: 19535524
references.citation: Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S230-2
references.pmid: 17822751
references.citation: J Clin Virol. 2009 Jul;45 Suppl 1:S29-37
references.pmid: 19651366
references.citation: J Med Virol. 2004 Sep;74(1):107-16
references.pmid: 15258976
references.citation: Vaccine. 2008 Aug 19;26 Suppl 10:K29-41
references.pmid: 18847555
references.citation: Cytopathology. 2006 Dec;17(6):374-81
references.pmid: 17168921
references.citation: Cancer. 2002 Apr 15;94(8):2199-210
references.pmid: 12001118
references.citation: Gynecol Oncol. 2005 Jun;97(3):908-15
references.pmid: 15943992
references.citation: Mol Cell Probes. 2004 Aug;18(4):251-3
references.pmid: 15271385
references.citation: Cancer Treat Rev. 2004 Apr;30(2):205-11
references.pmid: 15023438
references.citation: Vaccine. 2008 Aug 19;26 Suppl 10:K62-7
references.pmid: 18847558
references.citation: Obstet Gynecol Surv. 2004 Jul;59(7):543-53
references.pmid: 15199273
references.citation: J Clin Pathol. 2002 Apr;55(4):244-65
references.pmid: 11919208
references.citation: J Natl Cancer Inst. 2004 Feb 18;96(4):280-93
references.pmid: 14970277
references.citation: Gynecol Oncol. 1995 Feb;56(2):239-44
references.pmid: 7896192
references.citation: Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S7-11
references.pmid: 16154623
references.citation: Mol Biotechnol. 2002 Feb;20(2):163-79
references.pmid: 11876473
references.citation: N Engl J Med. 2007 Oct 18;357(16):1589-97
references.pmid: 17942872
references.citation: J Med Virol. 2004 May;73(1):65-70
references.pmid: 15042650
references.citation: J Virol Methods. 2009 Jan;155(1):61-6
references.pmid: 18955086
references.citation: Biotechniques. 2000 Aug;29(2):236-8, 240
references.pmid: 10948422
references.citation: J Cell Mol Med. 2007 Jul-Aug;11(4):881-91
references.pmid: 17760847
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):810-7
references.pmid: 18398022
references.citation: J Clin Microbiol. 2006 Apr;44(4):1310-7
references.pmid: 16597856
references.citation: J Natl Cancer Inst. 2000 Mar 1;92(5):397-402
references.pmid: 10700419
references.citation: J Virol Methods. 2007 Jun;142(1-2):204-12
references.pmid: 17379322
references.citation: J Med Virol. 2000 Oct;62(2):251-8
references.pmid: 11002256
references.citation: J Clin Microbiol. 2001 Oct;39(10):3656-65
references.pmid: 11574587
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):367-72
references.pmid: 15734959
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2536-45
references.pmid: 18842994
references.citation: Int J Cancer. 2005 May 10;114(6):973-6
references.pmid: 15645423
references.citation: J Virol Methods. 2006 Oct;137(1):58-62
references.pmid: 16828171
references.citation: J Virol. 2003 Oct;77(19):10186-201
references.pmid: 12970404
references.citation: J Clin Microbiol. 2009 Jul;47(7):2136-41
references.pmid: 19403762
references.citation: J Clin Microbiol. 2000 Feb;38(2):651-5
references.pmid: 10655362